JOHN THOMAS LITTELL

Allopathic & Osteopathic Physicians|Family Medicine KISSIMMEE, FL NPI 1609896323

General Payments — all program years on this page

$6,701.70

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 338
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $507.26 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $507.2620

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,398.9976
2019 $1,400.0760
2020 $730.7144
2021 $1,022.7661
2022 $790.2938
2023 $851.6239
2024 $507.2620

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096933785 Novo Nordisk Inc $19.72 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104889859 ABBVIE INC. $20.60 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104889861 ABBVIE INC. $20.27 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110533334 AstraZeneca Pharmaceuticals LP $17.55 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110534710 AstraZeneca Pharmaceuticals LP $18.87 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110540823 AstraZeneca Pharmaceuticals LP $16.12 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110545541 AstraZeneca Pharmaceuticals LP $16.97 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110550438 AstraZeneca Pharmaceuticals LP $18.33 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116612692 GlaxoSmithKline, LLC. $14.27 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116674643 GlaxoSmithKline, LLC. $14.43 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118079790 Boehringer Ingelheim Pharmaceuticals, Inc. $15.57 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119896477 Stryker Corporation $168.30 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135070975 Lilly USA, LLC $25.85 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135078671 Lilly USA, LLC $18.74 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135085298 Lilly USA, LLC $16.80 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135091743 Lilly USA, LLC $19.00 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135091745 Lilly USA, LLC $14.40 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139316648 Astellas Pharma US Inc $19.90 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146768200 IDORSIA PHARMACEUTICALS US INC $17.30 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146776108 IDORSIA PHARMACEUTICALS US INC $14.27 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.